Opus Genetics (IRD) Capital Expenditures Growth (1y) (2011 - 2019)
Opus Genetics (IRD) Capital Expenditures Growth (1y) (2011 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Opus Genetics |
355.39 Mn |
295.43 Mn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2019 |
537.41% |
| Mar 31, 2019 |
423.06% |
| Sep 30, 2018 |
932.99% |
| Jun 30, 2018 |
-93.02% |
| Mar 31, 2018 |
-36.44% |
| Dec 31, 2017 |
13,249.63% |
| Sep 30, 2017 |
359.97% |
| Jun 30, 2017 |
378.39% |
| Mar 31, 2017 |
-13.73% |
| Dec 31, 2016 |
-95.89% |
| Sep 30, 2016 |
-98.13% |
| Jun 30, 2016 |
-34.54% |
| Mar 31, 2016 |
-42.08% |
| Dec 31, 2015 |
-11.64% |
| Sep 30, 2015 |
151.64% |
| Jun 30, 2015 |
-57.36% |
| Mar 31, 2015 |
110.42% |
| Dec 31, 2014 |
200.68% |
| Sep 30, 2014 |
-64.46% |
| Jun 30, 2014 |
944.30% |
